(Q44479756)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12809582%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Randomized trial of three regimens to prevent tuberculosis in HIV-infected patients with anergy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12809582%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12809582%20AND%20SRC:MED&resulttype=core&format=json

Luis Fernando López-Cortés

4 November 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12809582%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Juan Pasquau

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12809582%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

Rafael Castillo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12809582%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Fernando Lozano

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12809582%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Miguel Angel García

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12809582%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Felipe Díez

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12809582%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

José Carlos Escribano

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12809582%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Jesús Canueto

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12809582%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Juan José Hernández

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12809582%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Rosa Polo

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12809582%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Francisco Javier Martínez-Marcos

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12809582%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

José María Kindelán

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12809582%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Rafael Rey

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12809582%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Grupo Andaluz para el estudio de las Enfermedades Infecciosas (GAEI)

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12809582%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

language of work or name

Spanish

0 references

publication date

1 June 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12809582%20AND%20SRC:MED&resulttype=core&format=json

Infectious Diseases and Clinical Microbiology

4 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12809582%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12809582%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12809582%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

287-292

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12809582%20AND%20SRC:MED&resulttype=core&format=json

High Risk of Active Tuberculosis in HIV-Infected Drug Users With Cutaneous Anergy

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972942-5

7 January 2021

Risk for Developing Tuberculosis among Anergic Patients Infected with HIV

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972942-5

7 January 2021

A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972942-5

7 January 2021

A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972942-5

7 January 2021

Tuberculosis and AIDS: a retrospective, longitudinal, multicentre study of Italian AIDS patients

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972942-5

7 January 2021

Effectiveness of isoniazid chemoprophylaxis for HIV-infected drug users at high risk for active tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972942-5

7 January 2021

Anergy, AIDS and tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972942-5

7 January 2021

Delayed-type hypersensitivity testing in Tanzanian adults with HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972942-5

7 January 2021

Comparison of two methods for the assessment of delayed-type hypersensitivity skin responses in patients with human immunodeficiency virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972942-5

7 January 2021

Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972942-5

7 January 2021

Twice weekly tuberculosis preventive therapy in HIV infection in Zambia

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972942-5

7 January 2021

Isoniazid preventive therapy for tuberculosis in HIV-1-infected adults: results of a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972942-5

7 January 2021

A prospective study of the risk of tuberculosis among HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972942-5

7 January 2021

Risk Factors for Tuberculosis in HIV-lnfected Persons

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972942-5

7 January 2021

Incidence of tuberculosis in the United States among HIV-infected persons. The Pulmonary Complications of HIV Infection Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972942-5

7 January 2021

[Evaluation of 2 tuberculosis chemoprophylaxis regimens in patients infected with human immunodeficiency virus. The GECMEI Group]

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972942-5

7 January 2021

Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS, the Adult AIDS Clinical Trials Group, the Pan American He

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972942-5

7 January 2021

Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972942-5

7 January 2021

10.1016/S0213-005X(03)72942-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12809582%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference